News

Poly Medicure announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 3.5 per equity Share (i.e. 70%) , subject to the approval of the shareholders.

Net profit of Poly Medicure declined 27.81% to Rs 66.29 crore in the quarter ended March 2026 as against Rs 91.83 crore during the previous quarter ended March 2025. Sales rose 21.25% to Rs 534.51 crore in the quarter ended March 2026 as against Rs 440.83 crore during the previous quarter ended March 2025.For the full year,net profit declined 4.85% to Rs 322.14 crore in the year ended March 2026 as against Rs 338.56 crore during the previous year ended March 2025. Sales rose 12.30% to Rs 1875.26 crore in the year ended March 2026 as against Rs 1669.83 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales534.51440.83 21 1875.261669.83 12 OPM %20.6527.10 -23.5927.12 - PBDT123.45143.88 -14 549.79535.15 3 PBT85.22122.85 -31 434.27452.52 -4 NP66.2991.83 -28 322.14338.56 -5 Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 25 May 2026.

Net profit of Poly Medicure declined 16.78% to Rs 70.93 crore in the quarter ended December 2025 as against Rs 85.23 crore during the previous quarter ended December 2024. Sales rose 16.37% to Rs 493.66 crore in the quarter ended December 2025 as against Rs 424.21 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales493.66424.21 16 OPM %22.5226.97 - PBDT133.17134.59 -1 PBT104.41113.23 -8 NP70.9385.23 -17 Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live News